Skip to main content

letter

. 1996 Sep 14;313(7058):686. doi: 10.1136/bmj.313.7058.686

Use of hormone replacement therapy. Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive.

PMCID: PMC2352007 PMID: 8811766

686

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bergkvist L., Adami H. O., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989 Aug 3;321(5):293–297. doi: 10.1056/NEJM198908033210505. [DOI] [PubMed] [Google Scholar]
Colditz G. A., Hankinson S. E., Hunter D. J., Willett W. C., Manson J. E., Stampfer M. J., Hennekens C., Rosner B., Speizer F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15;332(24):1589–1593. doi: 10.1056/NEJM199506153322401. [DOI] [PubMed] [Google Scholar]
Price E. H., Little H. K. Women need to be fully informed about risks of hormone replacement therapy. BMJ. 1996 May 18;312(7041):1301–1301. doi: 10.1136/bmj.312.7041.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wingo P. A., Layde P. M., Lee N. C., Rubin G., Ory H. W. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA. 1987 Jan 9;257(2):209–215. [PubMed] [Google Scholar]

ACTIONS

RESOURCES